Medovate receives clearance for SAFIRA and Australia and New Zealand

Medovate and its Brisbane-based distributor LTR Medical have announced they have secured both TGA (Therapeutic Goods Administration) Approval in Australia and inclusion on the WAND Database in New Zealand for its SAFIRA technology.

Show CommentsClose Comments

Leave a comment

%d bloggers like this: